BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• Drug Development

  ASCO15: TRACON Pharmaceuticals, Inc. Announces Positive Results Of TRC105 Clinical Trials In Sarcoma And Liver Cancer At The ASCO 2015 Annual Meeting

  June 1, 2015

   · 

  6 min read
• Drug Development

  ASCO15: OncoMed Pharmaceuticals, Inc. Presents Phase 1b Clinical Trial Data For Tarextumab In Small Cell Lung Cancer At The 2015 ASCO Annual Meeting

  June 1, 2015

   · 

  9 min read
• Drug Development

  OXiGENE Receives Guidance From FDA Supporting Phase III Trial Of Fosbretabulin/Bevacizumab Combination In Platinum-Resistant Ovarian Cancer

  June 1, 2015

   · 

  4 min read
• BioCapital

  Personal Genome Diagnostics Launches ImmunoSelect-R For Identification Of Immunogenic Cancer Mutations To Support Immuno-Oncology Drug Development

  June 1, 2015

   · 

  7 min read
• Drug Development

  ASCO15: VBL Therapeutics Reports Updated Interim Results From Phase II Clinical Trial Of VB-111 In Recurrent Glioblastoma (Rgbm)

  June 1, 2015

   · 

  7 min read
• Drug Development

  ASCO15: Onconova Therapeutics Inc. Presents Clinical Data On Rigosertib In Higher-Risk Myelodysplastic Syndromes (HR-MDS) At The 2015 ASCO Annual Meeting

  June 1, 2015

   · 

  7 min read
• Business

  Nuovo Biologics, LLC. Announces Academic-Biotech Collaboration With Auburn University’s Research Initiative In Cancer

  June 1, 2015

   · 

  1 min read
• Drug Development

  ASCO15: Data Presentations At ASCO Demonstrate The Ability Of Peregrine Pharmaceuticals, Inc.’ Bavituximab To Activate Tumor Targeting Immune Cells In PD-L1 Negative NSCLC Tumors

  June 1, 2015

   · 

  8 min read
• Drug Development

  ASCO15: Juno Therapeutics’s Investigational CAR T Cell Product Candidate JCAR015 Demonstrates Encouraging Clinical Responses In Patients With B-Cell Cancers

  June 1, 2015

   · 

  4 min read
• Drug Development

  Updated Data Showed Genentech’s Investigational Combination Of Cobimetinib And Zelboraf (Vemurafenib) Helps People With Advanced Melanoma Live For A Year Without Their Disease Worsening

  June 1, 2015

   · 

  9 min read